![](https://tracker.live.rns-distribution.com/track.live-rns/5033705_75d1671758db0ed18eba2dbba83793b2.png)
16 January 2024
Microsaic Systems plc
("Microsaic" or the "Company")
Restoration of Company's Shares to Trading on AIM,
Admission of Placing Shares
and TVR Update
Capitalised terms in this announcement carry the same meaning as in the Circular
or subsequent announcements, unless the context indicates otherwise
Microsaic Systems plc (AIM: MSYS), the developer of micro-electronic instruments and analytical solutions, announce the following updates.
Restoration
Following the publication of the Annual Report and Interim Results at 7.00 a.m. this morning, its Ordinary Shares are expected to be restored to trading on AIM at 7.30 a.m. today.
Admission of Placing Shares & Directors' Participation
The Company confirms that the 169,000,000 Placing Shares are expected to be admitted to trading on AIM at 8.00 a.m. today.
In addition, following the publication of the Annual Report and Interim Results, the Company confirms that Bob Moore and Nigel Burton have now entered into contractual obligations to subscribe for 9,040,000 and 2,000,000 Placing Shares respectively, in line with the expectations set out in the Conditional Placing announcement issued yesterday afternoon.
Total voting rights
Following Admission, the Company will have 179,178,185 Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore, from Admission, the total voting rights in the Company will be 179,178,185.
From Admission, the figure of 179,178,185 may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.
This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.
Enquiries:
Microsaic Systems plc Bob Moore, Acting Executive Chairman | +44 (0) 20 3657 0050 via TPI |
|
|
Singer Capital Markets Aubrey Powell / Angus Campbell / Oliver Platts | +44 (0)20 7496 3000 |
|
|
Turner Pope Investments (TPI) Limited Andy Thacker / James Pope | +44 (0) 20 3657 0050 |
About Microsaic Systems
Microsaic has over 20 years' experience in microelectronics and development of instrumentation. The Company has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application serving markets in diversified Industries, Human and Environmental Health. Microsaic's system solutions have enabled analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps in the process workflow.
Microsaic's products and solutions are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.